Anne Rogiers
Impact in
Papers in
- Oncology 19
- Cancer Immunotherapy and Biomarkers 15
- Cancer survivorship and care 4
-
- Brain Metastases and Treatment 12
- Cancer-related cognitive impairment studies 6
- Co-authors
- Bart Neyns (24 shared papers)Gil Awada (12 shared papers)Julia Katharina Schwarze (10 shared papers)Jennifer Cremer (8 shared papers)Peter Theuns (7 shared papers)Alex Michotte (6 shared papers)Johnny Duerinck (9 shared papers)Annelies H. Boekhout (4 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)Cancers (3 papers)Journal of Neuro-Oncology (2 papers)Annals of Oncology (2 papers)Drug Safety (2 papers)
- Partner nations
- BelgiumNetherlandsUnited States
In The Last Decade
Anne Rogiers
32 papers receiving 517 citations
Peers
Comparison fields: 5 of 82
- Genetics 143
- Oncology 293
- Pulmonary and Respiratory Medicine 161
- Biological Psychiatry 12
- Orthopedics and Sports Medicine 34
Countries citing papers authored by Anne Rogiers
This map shows the geographic impact of Anne Rogiers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Rogiers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Rogiers more than expected).
Fields of papers citing papers by Anne Rogiers
This network shows the impact of papers produced by Anne Rogiers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Rogiers. The network helps show where Anne Rogiers may publish in the future.
Co-authors
The 25 scholars most cited alongside Anne Rogiers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 86 | |
| 2 | 2017 | 52 | |
| 3 | 2019 | 48 | |
| 4 | 2019 | 47 | |
| 5 | 2020 | 42 | |
| 6 | 2008 | 39 | |
| 7 | 2020 | 31 | |
| 8 | 2021 | 30 | |
| 9 | 2020 | 19 | |
| 10 | 2022 | 17 | |
| 11 | 2021 | 16 | |
| 12 | The role of cytotoxic drugs in the treatment of central nervous system gliomas. | 2010 | 12 |
| 13 | 2015 | 11 | |
| 14 | 2006 | 11 | |
| 15 | 2019 | 11 | |
| 16 | 2023 | 8 | |
| 17 | 2020 | 8 | |
| 18 | 2017 | 7 | |
| 19 | 2018 | 4 | |
| 20 | 2023 | 3 |
About Anne Rogiers
Anne Rogiers is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Genetics, Biological Psychiatry and Psychiatry and Mental health, having authored 34 papers that have together received 521 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (15 papers), Brain Metastases and Treatment (12 papers), Glioma Diagnosis and Treatment (11 papers), Cancer-related cognitive impairment studies (6 papers), Tryptophan and brain disorders (4 papers), Cancer survivorship and care (4 papers), Long-Term Effects of COVID-19 (2 papers) and Schizophrenia research and treatment (2 papers). The work is most often cited by research in Genetics (143 citations), Oncology (293 citations), Pulmonary and Respiratory Medicine (161 citations), Biological Psychiatry (12 citations) and Orthopedics and Sports Medicine (34 citations). Anne Rogiers has collaborated with scholars based in Belgium, Netherlands and United States. Frequent co-authors include Bart Neyns, Gil Awada, Julia Katharina Schwarze, Jennifer Cremer, Peter Theuns, Alex Michotte, Johnny Duerinck, Annelies H. Boekhout, Christian U. Blank and Mark De Ridder. Their work appears in journals such as Journal of Clinical Oncology, Cancers, Journal of Neuro-Oncology, Annals of Oncology and Drug Safety.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.